W Osborne

Publications (1)

De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial.

The Lancet. Haematology

Avec: Richard E Clark , Fotios Polydoros , Jane F Apperley , Dragana Milojkovic , Katherine Rothwell , Christopher Pocock , Jennifer Byrne , Hugues de Lavallade , Wendy Osborne , Lisa Robinson , Stephen G O'Brien , Lucy Read , Letizia Foroni , Mhairi Copland

Réseau de co-auteurs

Richard E Clark 1 collaboration

Fotios Polydoros 1 collaboration

Jane F Apperley 1 collaboration

Dragana Milojkovic 1 collaboration

Katherine Rothwell 1 collaboration

Christopher Pocock 1 collaboration

Jennifer Byrne 1 collaboration

Hugues de Lavallade 1 collaboration

Wendy Osborne 1 collaboration

Lisa Robinson 1 collaboration

Stephen G O'Brien 1 collaboration

Lucy Read 1 collaboration

Letizia Foroni 1 collaboration

Mhairi Copland 1 collaboration